Neurology Articles

Neurology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prescot A et al. - These results are consistent with glutamatergic abnormalities in the ACC and insula in migraine patients during their interictal period compared to healthy controls. An alteration in excitatory amino acid neurotransmitters and their derivatives may be a contributing factor for migraineurs for a decrease in sensitivity for migraine or a consequence of the chronic migraine state. Such findings, if extrapolated to other regions of the brain would offer new opportunities to modulate central system as interictal or preemptive medications in these patients.

Related Articles

Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan
Headache: The Journal of Head and Face Pain, 10/15/09    Relevance Score: 64%

Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09    Relevance Score: 48%

CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09    Relevance Score: 47%

Aura migraines : Aura migraines double stroke risk
Internet Source, 11/02/09    Relevance Score: 47%

Normal Cortical Energy Metabolism in Migrainous Stroke. A 31P-MR Spectroscopy Study
Stroke, 10/20/09    Relevance Score: 47%

Today in Headache...keeping you current

Is botulinum toxin useful in treating headache? No
Current Treatment Options in Neurology, 12/17/09

Bilateral Acute Angle-closure Glaucoma in a Migraine Patient Receiving Topiramate: A Case Report
The Journal of Emergency Medicine, 12/17/09

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Pharmacology & Therapeutics, 12/17/09